Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genomic profiling and metastatic risk in early-stage non–small cell lung cancer

JTCVS Open(2023)10.1016/j.xjon.2023.10.016Source: DataRank Database

Genomic profiling and metastatic risk in early-stage non–small cell lung cancer is a research paper published in JTCVS Open (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.66)OA: goldTopics (20)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Elizabeth G. Dunne ORCID,Manendra B. Lankadasari,Brooke Mastrogiacomo ORCID,Tetsuhiko Asao ORCID,Stijn Vanstraelen ORCID

Live enrichment

PubMed:38204702 PMC:PMC10775106 OpenAlex:https://openalex.org/W4387749049

National Cancer Institute

Grant: P30 CA008748

National Cancer Institute

Grant: R01CA217169

National Cancer Institute

Grant: R01CA240472

National Institutes of Health

Grant: 5R01CA217169-04

BRMS1-mediated suppression of metastases in p53 mutant lung adenocarcinoma

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 1R01CA240472-01

Targeting SNP BRMS1v2 A273V/A273V to reduce metastases in lung adenocarcinoma

National Institutes of Health

FWCI

0.66

Citation Percentile

0.7%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.jtcvsopen.org/article/S2666273623003315/pdf

publisherhttp://www.jtcvsopen.org/article/S2666273623003315/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666273623003315?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666273623003315?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.xjon.2023.10.016

Fields of Study

Lung Cancer Treatments and MutationsCancer Genomics and DiagnosticsLung Cancer Diagnosis and Treatment03 medical and health sciences0302 clinical medicine

Keywords

Lung cancerProfiling (computer programming)OncologyBiologyStage (stratigraphy)MedicineComputational biologyInternal medicineComputer scienceGenomicsMetastasisctDNATumor HeterogeneityEarly-stage Non–small Cell Lung CancerSpecial Issue: Precision Therapy in Lung Cancer: Invited Expert Opinions

Sustainable Development Goals

SDG 0: Good health and well-being